| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -5.7e-05 | 1 |